The Transition to Home: Why Confidence is Critical to Patient Success

Sponsored by Noble

As more pharmaceutical therapies move from clinical settings into patients' homes, organizations are being asked to rethink how they support patients through that transition. In this video interview, Joe Reynolds, Head of User Experience Services at Noble, shares his perspective on what is driving the shift to home-based and self-administered care, and what companies need to understand about the patient experience to make that shift successful.

Reynolds discusses the benefits home-based therapy can offer patients, providers, and healthcare systems, along with the emotional and logistical challenges that come with self-administration. He speaks to the patient experience considerations that are most often overlooked during a transition from IV to subcutaneous or home-based delivery, and explains why education, training, and ongoing patient support are critical to building patient confidence and long-term adherence. He also describes Noble's Integrated Advantage, which combines human factors expertise, patient onboarding, training solutions, and commercialization support to help brands prepare therapies for home use.

For pharmaceutical companies and device developers planning for the future of home-based care, Reynolds offers a look at what will define successful drug delivery programs over the next five years, and what organizations should be doing now to prepare. Viewers will come away with a clearer understanding of how patient-centered development, early planning, and integrated support can help therapies succeed once they reach the home.